CORRECTION: Trulieve Announces Registration Statement Filing

This press release corrects a prior version the company published on July 7, 2022, to update the timing for effectiveness of the registration statement.

TALLAHASSEE, Fla.July 8, 2022 – PRESS RELEASE – Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., announced that it filed a shelf registration statement on Form S-3with the U.S. Securities and Exchange Commission (SEC) on July 7, 2022, to register a base shelf prospectus and to register for resale select subordinate voting shares of the company. The registration statement is expected to become effective upon its acceptance by the SEC.

Trulieve became eligible to file the S-3 registration statement following one year of reporting under the previously filed registration statement and associated amendments on Form S-1. The S-3 filing provides a shelf registration which may provide the company with additional flexibility in its future financing opportunities.

Editor’s note: Trulieve CEO Kim Rivers said publicly that the filing of the S-3 is to provide optionality in the event the company wants to do any type of raise in the future, but there are no plans to use it currently.

The specific terms of any securities to be offered pursuant to the base prospectus will be specified in a prospectus supplement. The resale prospectus covers the resale registration by selling shareholders of up to 72,288,199 subordinate voting shares. Selling shareholders may offer, sell or distribute all or a portion of their subordinate voting shares publicly or through private transactions at prevailing market prices or at negotiated prices. However, the registration of the securities covered by the registration statement does not necessarily indicate that the company and/or selling shareholders will offer or sell any subordinate voting shares in connection with such registration or within any specific timeframe.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

Trulieve has filed a registration statement (including a prospectus) with the SEC for the registration of shares to which this communication relates. The company advises reading the prospectus in that registration statement and other documents it has filed with the SEC for more complete information about the company and any applicable offering. These documents are available for free by visiting EDGAR on the SEC website at www.sec.gov.

Alternatively, Trulieve and any participant in any applicable offering will arrange to send the prospectus to those who request it by calling toll-free 1-844-878-5438.

Share This Content